KATHERINE STONE: Open Payments
NPI 1538208517 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 27 payments from 10 companies in 2025. Trend: 2023 $520 · 2024 $746 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $190 |
| Merck Sharp & Dohme LLC | 4 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $74 |
| United Therapeutics Corporation | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Novo Nordisk Inc | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| BridgeBio Pharma, Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: CARDIOMEMS, WINREVAIR, Kerendia, FARXIGA, Wegovy, LEQVIO, Tyvaso, Adempas.
Industry payments across NC — which companies pay providers there.
